Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,875 | 9 | 74.3% |
| Unspecified | $3,770 | 3 | 25.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $10,875 | 9 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $3,770 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $14,645 | 12 | Allergan Inc. ($10,875) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2017 | Allergan Inc. | ACZONE DAPSONE GEL 7.5 (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/22/2017 | Valeant Pharmaceuticals North America LLC | — | — | Cash or cash equivalent | $2,000.00 | Research |
| Study: A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris | ||||||
| 08/10/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| 07/19/2017 | Valeant Pharmaceuticals North America LLC | — | — | Cash or cash equivalent | $750.00 | Research |
| Study: A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris | ||||||
| 06/15/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| 06/15/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| 04/25/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 03/08/2017 | Valeant Pharmaceuticals North America LLC | — | — | Cash or cash equivalent | $1,020.00 | Research |
| Study: Randomized Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-123 Lotion in Comparison With Tazorac Cream in Subjects With Moderate to Severe Acne Vulgaris Under Maximal Use Conditions | ||||||
| 02/23/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| 01/19/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| 01/17/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,375.00 | General |
| 01/17/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris | Valeant Pharmaceuticals North America LLC | $2,750 | 2 |
| Randomized Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-123 Lotion in Comparison With Tazorac Cream in Subjects With Moderate to Severe Acne Vulgaris Under Maximal Use Conditions | Valeant Pharmaceuticals North America LLC | $1,020 | 1 |
About Dr. Michael Jarratt, M.D
Dr. Michael Jarratt, M.D is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114909157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Jarratt, M.D has received a total of $14,645 in payments from pharmaceutical and medical device companies, with $14,645 received in 2017. These payments were reported across 12 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,875).
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 11/16/2005
- Last Updated 03/21/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114909157
Products in Payments
- ACZONE DAPSONE GEL 7.5 (Drug) $1,000
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608